Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Positive Airway Pressure Devices Market size was valued at USD 3 billion in 2024 and is anticipated to surpass USD 5.9 billion by 2037, registering a CAGR of 5.8% during the forecast timeline i.e 2025-2037. In 2025, the industry size of positive airway pressure devices is evaluated at USD 3.1 billion.
The PAP devices market is experiencing a sound growth pattern due to the rising burden of sleep-disorders and awareness of its comorbidities. Furthermore, the rise in the incidence of obstructive sleep apnea (OSA) is necessitating effective therapeutic interventions. For instance, in December 2022, it was published by the National Library of Medicine that, one of the most prevalent sleep disorders in the world is obstructive sleep apnea (OSA) with 936 million adults aged 30 to 69. In addition, in the U.S., OSA affects 33.9% of men and 17.4% of women.
Furthermore, the innovation towards more advanced PAP devices that are more patient compliant and friendly, which provide best-fit pressure according to unique patient respiratory profiles fuel the demand. For instance, in January 2025, ResMed declared that AirSense 11 made available in India. It is the next-generation continuous positive airway pressure (CPAP) device to make it simpler for people with obstructive sleep apnea (OSA) to begin and continue therapy. The intersection of these technological advancements, growing prevalence of the disease, and better patient management solutions is a demonstration of the existing growth trend of the positive airway pressure (PAP) devices market.
Positive Airway Pressure Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Integration of remote monitoring and telehealth: The major growth driver of the positive airway pressure devices market is integration of remote monitoring and telehealth because of its ability to improve patient compliance as well as maximize therapeutic outcomes. For instance, in December 2024, by combining the FDA-approved EnsoSleep PPG software with BodiMetrics' FDA-approved Circulator Pro smart ring, the two companies have teamed together to improve at-home sleep apnea testing and monitoring. It facilitates instantaneous feedback on utilization, effectiveness, and possible side effects by the patients to make timely settings to the therapy and intervene appropriately.
- Rising adoption of minimally invasive surgical procedures: The most prominent driver in the positive airway pressure (PAP) devices market is the increased uses of minimally invasive surgical treatments in an effort to secure optimal airway patency and long-term therapy effectiveness. For instance, in February 2025, Signifier Medical expanded access to sleep apnea therapy for more medicare and medicaid patients with the release of the new eXciteOSA product update. Although minimal invasive therapy re-establishes anatomical obstruction, it may be necessary to use adjunctive PAP therapy to treat ongoing or changing respiratory disease, especially in the post-operative healing phase.
Challenges
- Device comfort and design: Maximization of device comfort and ergonomic configuration is a key barrier to worldwide compliance with positive airway pressure devices market. Differences in facial structure between patients require customized mask fit, often being thwarted by pressure point pain, air leaks, or feelings of claustrophobia. In addition, incorporation of sound reduction technology, component miniaturization, and user-friendliness interfaces remains critical to avert patient aversion and enhance long-term compliance. Therefore, manufacturers need to prioritize iterative design improvement using the latest materials and anthropometric information to produce equipment that is optimized for patient comfort as well as therapeutic impact.
- Cybersecurity risks: The rising prevalence of connectivity features in positive airway pressure (PAP) devices market is a novel cybersecurity risk, and it is important to scrutinize this closely. Patient physiological information, such as sleep and respiratory information, needs to be transmitted with strong encryption and authentication to avoid unauthorized access and data tampering. In addition, the threat of hackers compromising device firmware or software poses compromised therapeutic effectiveness and patient safety. Thus, the manufacturers need to take it upon themselves to adhere to sound cybersecurity practices, following set industry standards and regulation, in a bid to counteract these emerging threats while upholding the integrity of patient data and device performance.
Positive Airway Pressure Devices Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.8% |
|
Base Year Market Size (2024) |
USD 3 billion |
|
Forecast Year Market Size (2037) |
USD 5.9 billion |
|
Regional Scope |
|
Positive Airway Pressure Devices Segmentation
Application (Obstructive Sleep Apnea, COPD, Respiratory Failures)
Obstructive sleep apnea segment is likely to capture around 56.1% positive airway pressure devices market share by the end of 2037, attributed to the disease prevalence worldwide along with published PAP therapy effectiveness in management as a first-line. OSA, which involves repeated cycles of periodic upper airway collapse on lying down, requires continuous positive airway pressure to obtain patency. For instance, in September 2022, Transcend Micro, the smallest and lightest portable continuous positive airway pressure (CPAP) device in the world, was unveiled by Transcend Inc. to make it easier for patients with obstructive sleep apnea.
Product Type (APAP, CPAP, BiPAP)
The continuous positive airway pressure (CPAP) segment dominates the positive airway pressure (PAP) devices market because of its proven effectiveness and extensive clinical use. CPAP devices, providing a steady flow of pressurized air, effectively treat obstructive sleep apnea, an upper airway collapse disorder with multiple collapses. The ease of CPAP treatment, coupled with its established track record of bettering patient results, is the reason for widespread use by both patients and clinicians. For instance, in September 2024, by combining its popular myAir consumer software with Apple and Android smartwatches, ResMed helps consumers better manage their sleep health and adhere to continuous positive airway pressure (CPAP) treatment.
Our in-depth analysis of the global market includes the following segments:
|
Product Type |
|
|
Application |
|
|
End user |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportPositive Airway Pressure Devices Industry - Regional Synopsis
North America Market Statistics
North America positive airway pressure devices market is set to account for revenue share of more than 43.2% by the end of 2037, characterized by the advanced features including connectivity to mobile apps, enhanced comfort, and quieter operation are being introduced by manufacturers. For example, React Health unveiled the Luna TravelPAP, a portable and lightweight travel-positive airway pressure device, in July 2023. It has a 4–20 hPA pressure range, a 0–60 minutes ramp time, and a noise level of less than 30 dBA.
The most significant growth driver in the U.S. positive airway pressure devices market is significant investments made by the companies to enhance their treatment portfolios. For instance, in January 2022, Cathay Capital declared its strategic investment in CPAP.com. as it caters to the USD 3.7 billion for devices used to treat obstructive sleep apnea (OSA). Through this deal, CPAP.com got the assistance of Cathay Capital as it advances its growth and solidifies its position as a pioneer in the treatment of sleep apnea.
In Canada the growth in the positive airway pressure devices market is growing rapidly due to the expanding market activities involving companies to innovate and discover the effective treatments. For instance, in December 2024, the Coordinated Accessible National (CAN) Health Network allowed NovaResp Technologies to address the OSA challenge with its innovative software, cMAP, an AI-enabled platform that can be installed on any CPAP machine. It predicted and prevented apneas in real-time, allowing CPAP therapy to deliver lower, more comfortable air pressures resulting in fewer breathing interruptions during sleep and a significantly improved experience for patients.
Asia Pacific Market Analysis
The Asia Pacific positive airway pressure devices market is expanding at a rapid pace owing to the urbanization, the rise in the middle class, and the increased incidence of sleep apnea. The market is being stimulated by constant advancements that improve patient comfort, automatically alter pressure levels according to user needs, and increase treatment efficacy. In addition, user experience is being improved and market penetration is rising with the release of travel-friendly and portable CPAP equipment and the incorporation of intelligent connectivity features for remote monitoring.
In India, the market is spurred by the continuous development in devices to treat the sleep disorders. Moreover, the relentless governmental support in boasting such discoveries help the market to gain innovative products. For instance, in June 2021, it was published that, the Jivan Vayu, a gadget created by the Indian Institute of Technology, Ropar, can be used in place of a CPAP machine. This is the only gadget of its sort in the country that can operate without electricity and is compatible with both types of oxygen producing equipment, such as hospital oxygen pipelines and O2 cylinders.
In China, the PAP devices market is witnessing substantial growth owing to revolutions made by prominent player present in the country to finesse the sleeping disorders and render sound sleep patterns. For instance, in January 2024, in order to help the people sleep better and lower their health risks, DeRUCCI announced to introduce a new line of sleep health technologies at CES 2024. These technologies include intelligent voice control panels, curtain tracks, anti-snore pillows, award-winning smart mattresses, and other smart IoT sleep solutions.
Companies Dominating the Positive Airway Pressure Devices Landscape
- Varon
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Servona GmbH
- ResMed
- Philips Respironics
- Medtronic, Inc.
- Drive Devilbliss Healthcare Ltd.
- Curative Medical Inc.
- Armstrong Medical
The competitive dynamics of the positive airway pressure devices market is dominated by the number of partnerships, innovations, and collaborations between companies to broaden their market reach and integrate cutting-edge technologies. For instance, in September 2024, Software called SOMNUM designed by Honeynaps to help in the diagnosis of respiratory and sleep disorders was approved by the FDA. It examines physiological data from sleep tests that have already been recorded. The program recognizes breathing, arousal, leg movement, and sleep stage events automatically.
Here's the list of some key players:
In the News
- In March 2025, BlueSleep and Moona Health established a strategic clinical cooperation with the goal of transforming sleep therapy choices for those with sleep disorders.
- In September 2024, Big Health announced that the FDA has approved SleepioRx, a digital therapy, to treat persistent insomnia in adults as a supplement to standard care.
Author Credits: Radhika Pawar
- Report ID: 7421
- Published Date: Apr 01, 2025
- Report Format: PDF, PPT
